- Home
- MTLS vs ARCT Comparison
MTLS vs ARCT Comparison
Compare MTLS & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTLS
- ARCT
- Stock Information
- Founded
- MTLS 1990
- ARCT 2013
- Country
- MTLS Belgium
- ARCT United States
- Employees
- MTLS N/A
- ARCT N/A
- Industry
- MTLS Computer Software: Prepackaged Software
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- MTLS Technology
- ARCT Health Care
- Exchange
- MTLS Nasdaq
- ARCT Nasdaq
- Market Cap
- MTLS 349.7M
- ARCT 320.8M
- IPO Year
- MTLS 2014
- ARCT N/A
- Fundamental
- Price
- MTLS $5.17
- ARCT $18.05
- Analyst Decision
- MTLS
- ARCT Strong Buy
- Analyst Count
- MTLS 0
- ARCT 10
- Target Price
- MTLS N/A
- ARCT $50.88
- AVG Volume (30 Days)
- MTLS 121.7K
- ARCT 493.8K
- Earning Date
- MTLS 10-23-2025
- ARCT 11-06-2025
- Dividend Yield
- MTLS N/A
- ARCT N/A
- EPS Growth
- MTLS N/A
- ARCT N/A
- EPS
- MTLS 0.11
- ARCT N/A
- Revenue
- MTLS $311,850,851.00
- ARCT $122,122,000.00
- Revenue This Year
- MTLS $2.98
- ARCT N/A
- Revenue Next Year
- MTLS $7.09
- ARCT $28.92
- P/E Ratio
- MTLS $47.83
- ARCT N/A
- Revenue Growth
- MTLS 2.98
- ARCT N/A
- 52 Week Low
- MTLS $3.93
- ARCT $8.04
- 52 Week High
- MTLS $9.69
- ARCT $25.88
- Technical
- Relative Strength Index (RSI)
- MTLS 51.80
- ARCT 58.87
- Support Level
- MTLS $4.96
- ARCT $16.54
- Resistance Level
- MTLS $5.24
- ARCT $19.50
- Average True Range (ATR)
- MTLS 0.18
- ARCT 1.08
- MACD
- MTLS 0.02
- ARCT -0.08
- Stochastic Oscillator
- MTLS 64.29
- ARCT 56.46
About MTLS Materialise NV
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.